Resuscitation-associated endotheliopathy (RAsE): a conceptual framework based on a systematic review and meta-analysis.

Endothelial dysfunction Glycocalyx Microcirculation Resuscitation-associated endotheliopathy Shock

Journal

Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575

Informations de publication

Date de publication:
22 Nov 2023
Historique:
received: 10 05 2023
accepted: 06 11 2023
medline: 23 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

Shock-induced endotheliopathy (SHINE), defined as a profound sympathoadrenal hyperactivation in shock states leading to endothelial activation, glycocalyx damage, and eventual compromise of end-organ perfusion, was first described in 2017. The aggressive resuscitation therapies utilised in treating shock states could potentially lead to further worsening endothelial activation and end-organ dysfunction. This study aimed to systematically review the literature on resuscitation-associated and resuscitation-induced endotheliopathy. A predetermined structured search of literature published over an 11-year and 6-month period (1 January 2011 to 31 July 2023) was performed in two indexed databases (PubMed/MEDLINE and Embase) per PRISMA guidelines. Inclusion was restricted to original studies published in English (or with English translation) reporting on endothelial dysfunction in critically ill human subjects undergoing resuscitation interventions. Reviews or studies conducted in animals were excluded. Qualitative synthesis of studies meeting the inclusion criteria was performed. Studies reporting comparable biomarkers of endothelial dysfunction post-resuscitation were included in the quantitative meta-analysis. Thirty-two studies met the inclusion criteria and were included in the final qualitative synthesis. Most of these studies (47%) reported on a combination of mediators released from endothelial cells and biomarkers of glycocalyx breakdown, while only 22% reported on microvascular flow changes. Only ten individual studies were included in the quantitative meta-analysis based on the comparability of the parameters assessed. Eight studies measured syndecan-1, with a heterogeneity index, I Resuscitation-associated endotheliopathy (RAsE) refers to worsening endothelial dysfunction resulting from acute resuscitative therapies administered in shock states. In the included studies, syndecan-1 had the highest frequency of assessment in the post-resuscitation period, and changes in concentrations showed a statistically significant effect of the resuscitation. There are inadequate data available in this area, and further research and standardisation of the ideal assessment and panel of biomarkers are urgently needed.

Identifiants

pubmed: 37990333
doi: 10.1186/s13643-023-02385-0
pii: 10.1186/s13643-023-02385-0
pmc: PMC10664580
doi:

Substances chimiques

Syndecan-1 0
Biomarkers 0

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

221

Informations de copyright

© 2023. The Author(s).

Références

Crit Care. 2017 Jun 23;21(1):155
pubmed: 28641580
J Crit Care. 2017 Feb;37:13-18
pubmed: 27610586
Clin Chim Acta. 2004 Oct;348(1-2):131-7
pubmed: 15369746
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Shock. 2018 Apr;49(4):420-428
pubmed: 28945676
Resuscitation. 2017 Dec;121:179-186
pubmed: 28947390
J Intensive Care. 2021 Jan 5;9(1):1
pubmed: 33402229
Resuscitation. 2022 Jan;170:115-125
pubmed: 34838662
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
J Crit Care. 2016 Apr;32:16-20
pubmed: 26810483
Clin Hemorheol Microcirc. 2019;71(1):71-82
pubmed: 29843227
J Trauma Acute Care Surg. 2018 Jan;84(1):81-88
pubmed: 28885470
Front Med (Lausanne). 2020 Oct 07;7:542567
pubmed: 33117828
Intensive Care Med Exp. 2023 Apr 17;11(1):21
pubmed: 37062769
Shock. 2012 Oct;38(4):341-50
pubmed: 22777113
Crit Care. 2016 Nov 28;20(1):387
pubmed: 27890016
Intensive Care Med. 2010 Nov;36(11):1813-25
pubmed: 20689916
Br J Anaesth. 2015 Sep;115(3):366-75
pubmed: 26269467
Ann Transl Med. 2020 Jun;8(12):793
pubmed: 32647718
Shock. 2020 Feb;53(2):156-163
pubmed: 31389906
Burns. 2020 Mar;46(2):386-393
pubmed: 31866179
Am J Respir Crit Care Med. 2022 Feb 1;205(3):324-329
pubmed: 34813414
Dtsch Arztebl Int. 2018 Nov 9;115(45):757-768
pubmed: 30573009
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
Anesth Analg. 2018 Oct;127(4):920-927
pubmed: 29863610
Crit Care. 2017 Feb 9;21(1):25
pubmed: 28179016
Scand J Trauma Resusc Emerg Med. 2018 Nov 21;26(1):102
pubmed: 30463625
Front Pediatr. 2019 Jul 09;7:273
pubmed: 31338353
Scand J Trauma Resusc Emerg Med. 2013 Sep 14;21:70
pubmed: 24034700
Open Med (Wars). 2017 Dec 22;12:409-416
pubmed: 29318186
Crit Care. 2022 Sep 12;26(1):273
pubmed: 36096866
Glob Cardiol Sci Pract. 2020 Nov 30;2020(2):e202029
pubmed: 33447608
Eur Heart J Acute Cardiovasc Care. 2020 Nov;9(4_suppl):S100-S109
pubmed: 32004081
Pediatr Crit Care Med. 2020 Feb;21(2):e52-e106
pubmed: 32032273
Transfusion. 2021 Jul;61 Suppl 1:S49-S57
pubmed: 34269460
J Trauma Acute Care Surg. 2022 Nov 1;93(5):588-596
pubmed: 35610738
Thromb J. 2019 May 30;17:10
pubmed: 31160889
Intensive Care Med. 2000 Jan;26(1):38-44
pubmed: 10663278
Shock. 2015 May;43(5):450-5
pubmed: 25692257
Crit Care Clin. 2020 Apr;36(2):323-331
pubmed: 32172816
Crit Care Med. 2021 Nov 1;49(11):e1063-e1143
pubmed: 34605781
Clin Physiol Funct Imaging. 2010 Nov;30(6):432-8
pubmed: 20718805
Crit Care. 2021 Aug 3;25(1):271
pubmed: 34344416
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1043-1054
pubmed: 29882682
JCI Insight. 2020 Apr 23;5(8):
pubmed: 32229722
N Engl J Med. 2013 Oct 31;369(18):1726-34
pubmed: 24171518
Pediatr Crit Care Med. 2023 Mar 1;24(3):213-221
pubmed: 36598246
Crit Care. 2019 Mar 27;23(1):98
pubmed: 30917843
J Burn Care Res. 2014 Mar-Apr;35(2):169-75
pubmed: 24165669
Resuscitation. 2016 Oct;107:71-9
pubmed: 27523954
Am J Pathol. 2020 Apr;190(4):732-741
pubmed: 32035884
Crit Care. 2019 Jul 24;23(1):260
pubmed: 31340868
Am Heart J. 2020 Jan;219:9-20
pubmed: 31710844
Crit Care. 2019 Jul 23;23(1):259
pubmed: 31337421
Am J Emerg Med. 2021 Apr;42:83-89
pubmed: 33493833
Am J Case Rep. 2018 Feb 16;19:176-182
pubmed: 29449526
Crit Care. 2014 Sep 05;18(5):466
pubmed: 25189175
Biomed Res Int. 2016;2016:7463130
pubmed: 28044135
Chest. 2020 Dec;158(6):e267-e268
pubmed: 32622823
Cell Tissue Res. 2010 Jan;339(1):31-46
pubmed: 19597846
Front Immunol. 2020 Feb 18;11:227
pubmed: 32133006
Pediatrics. 2022 Jan 1;149(1 Suppl 1):S97-S102
pubmed: 34970676
Resuscitation. 2013 Dec;84(12):1717-22
pubmed: 23871865

Auteurs

Nchafatso G Obonyo (NG)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia. g.obonyo@uq.edu.au.
Faculty of Medicine, The University of Queensland, Brisbane, Australia. g.obonyo@uq.edu.au.
Initiative to Develop African Research Leaders (IDeAL), Kilifi, Kenya. g.obonyo@uq.edu.au.
KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. g.obonyo@uq.edu.au.
Wellcome Trust Centre for Global Health Research, Imperial College London, London, UK. g.obonyo@uq.edu.au.
Institute of Molecular Bioscience, The University of Queensland, Brisbane, Australia. g.obonyo@uq.edu.au.

Declan P Sela (DP)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Institute of Molecular Bioscience, The University of Queensland, Brisbane, Australia.

Sainath Raman (S)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia.
Paediatric Intensive Care Unit, Queensland Children's Hospital, South Brisbane, QLD, Australia.

Reema Rachakonda (R)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Bailey Schneider (B)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Louise E See Hoe (LES)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Jonathon P Fanning (JP)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Division of Cardiac Surgery, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Intensive Care Unit, St. Andrews War Memorial Hospital, Brisbane, QLD, Australia.

Gianluigi Li Bassi (GL)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Institute of Molecular Bioscience, The University of Queensland, Brisbane, Australia.
Intensive Care Unit, St. Andrews War Memorial Hospital, Brisbane, QLD, Australia.

Kathryn Maitland (K)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Imperial College London, London, UK.

Jacky Y Suen (JY)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Institute of Molecular Bioscience, The University of Queensland, Brisbane, Australia.

John F Fraser (JF)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Institute of Molecular Bioscience, The University of Queensland, Brisbane, Australia.
Intensive Care Unit, St. Andrews War Memorial Hospital, Brisbane, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH